Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Direct ✕Franklin Asian Equity Fund · Direct ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundFranklin Asian Equity Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseNippon IndiaFranklin
NAV₹666.3420₹45.3436
NAV date20 Nov 202619 Nov 2026
History13.9 years13.9 years
Expense ratio1.0%1.2%
Stars★★★★★★★★★★
Growth Score75.2065.10

Returns

Nippon India Pharma FundFranklin Asian Equity Fund
1 month+11.40%−1.78%
3 months+3.74%−8.66%
6 months+8.55%−3.66%
YTD+16.94%+16.21%
1 year+15.26%+20.98%
3 years (CAGR)+17.96%+19.44%
5 years (CAGR)+15.40%+6.81%
10 years (CAGR)+16.61%+10.32%
Since launch+17.63%+9.32%

Risk

Nippon India Pharma FundFranklin Asian Equity Fund
Volatility14.1%17.7%
Downside volatility9.0%10.4%
Sharpe0.810.73
Sortino1.281.25
Calmar1.221.37
Return / risk1.271.10
Deepest fall−24.02%−40.20%
Days to recover4451074
Below its high+0.00%−11.70%

Against benchmark

Nippon India Pharma FundFranklin Asian Equity Fund
Alpha−1.86%+10.56%
Beta0.890.51
R²89.5%21.3%
Up capture85.2%69.9%
Down capture88.7%1.9%
Tracking error4.8%17.6%
Information ratio−0.690.45
Treynor0.120.26

Consistency

Nippon India Pharma FundFranklin Asian Equity Fund
Best 1-year+90.70%+71.57%
Middle 1-year+13.13%+10.63%
Worst 1-year−15.12%−32.93%
1-year periods with a loss23.2%26.1%
Middle 3-year+19.82%+8.99%
Positive months63.9%58.3%
Best day+3.40%+5.04%
Worst day−3.21%−6.66%
Worst 5% day−1.38%−1.67%
Positive days53.7%56.9%
NAVs a year247247

SIP of ₹10,000 a month

Nippon India Pharma FundFranklin Asian Equity Fund
5-year XIRR+18.24%+15.08%
5-year value₹9,54,076₹8,81,338
3-year XIRR+14.26%+19.77%
1-year XIRR+22.08%+4.81%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth